Wegovy Pill Cost: Complete Pricing Guide With and Without Insurance

Oral Wegovy Pill Cash Price (Without Insurance)

Novo Nordisk priced the oral Wegovy pill at approximately $5 per day, making it the most affordable branded semaglutide option available. For patients paying out of pocket:

These prices are significantly lower than the list price of injectable Wegovy, which runs approximately $1,350/month at the maintenance dose. The pricing strategy reflects Novo Nordisk's goal of expanding access and competing with compounded semaglutide providers. For a broader look at semaglutide pricing, see our semaglutide cost without insurance guide.

Oral Wegovy Pill Cost With Insurance

With insurance coverage, the cost of oral Wegovy drops substantially. Novo Nordisk has stated that insured patients may pay as little as $25 per month or less through a combination of insurance coverage and manufacturer savings programs.

Commercial Insurance

Most employer-sponsored and individual commercial insurance plans are beginning to cover oral Wegovy. Since it carries the same FDA-approved indications as injectable Wegovy (chronic weight management and cardiovascular risk reduction), plans that already cover injectable Wegovy generally extend coverage to the oral formulation. However, coverage is not universal:

• Some plans may require prior authorization for oral Wegovy
• Step therapy requirements may mandate trying the pill before the injection (or vice versa)
• Formulary tier placement affects copay — preferred tier means lower cost
• Deductibles must typically be met before coverage kicks in

Medicare and Medicaid

Medicare coverage for GLP-1 weight loss medications has been evolving. The FDA's approval of Wegovy for cardiovascular risk reduction (in addition to weight management) opened the door for Medicare Part D coverage for qualifying patients. However, coverage varies by plan and indication. Medicaid coverage differs by state.

For a comprehensive overview of GLP-1 insurance coverage options, see our GLP-1 insurance coverage guide and Wegovy cost with insurance guide.

Savings Programs and Patient Assistance

Novo Nordisk offers several programs to reduce the cost of oral Wegovy:

Wegovy Savings Card

The Wegovy savings card is available to commercially insured patients. Eligible patients may pay as little as $0 per 28-day supply for a limited time, with ongoing savings reducing copays. The savings card is not available for patients with government insurance (Medicare, Medicaid, Tricare) or those without insurance.

Novo Nordisk Patient Assistance Program

Uninsured or underinsured patients who meet income requirements may qualify for Novo Nordisk's patient assistance program, which can provide Wegovy at no cost. Eligibility requirements include US residency, no commercial insurance or government insurance that covers Wegovy, and household income below a specified threshold.

Manufacturer Coupons

Novo Nordisk periodically offers promotional coupons, especially during the oral Wegovy launch period. Check the Wegovy coupon page for current offers. Pharmacy discount programs like GoodRx may also offer discounts on the oral pill, though availability varies.

Oral Wegovy Pill vs. Other GLP-1 Options: Cost Comparison

Understanding how the oral Wegovy pill compares in cost to other weight loss medications helps you make an informed choice:

The oral Wegovy pill stands out as the most affordable branded GLP-1 medication for cash-paying patients. For those with insurance, out-of-pocket costs are similar across branded options. The key differentiator for insured patients is whether their plan covers weight loss medications at all. For a detailed comparison of the leading options, see our tirzepatide vs. semaglutide comparison.

Oral Wegovy Pill vs. Injectable: Beyond Cost

Cost is an important factor, but it is not the only consideration when choosing between oral and injectable Wegovy. Here is how they compare across key dimensions:

Weight Loss Efficacy

Clinical data shows comparable efficacy between the two formulations. The OASIS 4 trial reported 16.6% mean weight loss with the oral pill (25 mg daily) at 64 weeks among adherent participants. The STEP trials showed approximately 15% mean weight loss with injectable Wegovy (2.4 mg weekly). One-third of oral pill participants achieved at least 20% weight loss, versus under 3% with placebo. For more on the injectable version, see our Wegovy weight loss timeline.

Convenience and Administration

The oral pill offers clear advantages for needle-averse patients. However, it comes with specific administration requirements:

• Must be taken on an empty stomach first thing in the morning
• Swallowed with no more than 4 ounces (half a glass) of plain water
• Must wait at least 30 minutes before eating, drinking, or taking other medications
• No refrigeration required (unlike injectable Wegovy)
• Taken daily rather than weekly

For some patients, the daily routine may feel more manageable. For others, a once-weekly injection is simpler. See our Wegovy pill vs. injection comparison for a comprehensive side-by-side analysis.

Side Effect Profiles

Both oral and injectable semaglutide share similar side effects, primarily gastrointestinal issues during dose escalation. Nausea, diarrhea, and constipation are the most common. The oral pill contains SNAC (salcaprozate sodium), an absorption enhancer that helps the peptide survive stomach acid. A February 2026 study raised preliminary questions about SNAC's effects on gut bacteria, though findings were limited to animal models. For details on the oral formulation, see our oral Wegovy guide.

How to Get the Oral Wegovy Pill

The oral Wegovy pill is now broadly available across the United States. Here are the most common access pathways:

Through Your Primary Care Provider

Any licensed physician can prescribe oral Wegovy for eligible patients. If you have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (such as high blood pressure, type 2 diabetes, or high cholesterol), you may qualify. Ask your doctor about starting semaglutide for weight loss.

Through Telehealth Platforms

Telehealth platforms like Hims (which recently partnered with Novo Nordisk) and others offer online consultations and home delivery. This is the most convenient option if you prefer not to visit a doctor's office. See our telehealth GLP-1 guide for more details.

Pharmacy Availability

Oral Wegovy is available at major pharmacies including CVS, Walgreens, Walmart, and mail-order pharmacies. Unlike earlier GLP-1 medication launches, Novo Nordisk proactively managed supply to avoid the shortage issues that plagued Ozempic and injectable Wegovy.

Strategies to Minimize Oral Wegovy Cost

Several strategies can help reduce what you pay for oral Wegovy:

• Use the Wegovy savings card: Commercially insured patients may pay $0-25 per fill. Enroll through the Novo Nordisk website or ask your pharmacy.
• Check insurance formulary: If oral Wegovy is on a preferred tier, your copay will be lower. Ask your insurer about tier placement.
• Request prior authorization: If your plan requires it, work with your prescriber to submit the authorization proactively to avoid delays and potential denials.
• Compare pharmacy prices: Cash prices can vary significantly between pharmacies. Use discount programs or call ahead to compare.
• Consider manufacturer patient assistance: If uninsured and income-eligible, you may qualify for free medication through Novo Nordisk's patient assistance program.
• Explore employer benefits: Some employer wellness programs cover GLP-1 medications outside of standard insurance. Ask your HR department.
• Use maintenance dosing once at goal weight: Some patients may be able to maintain weight loss at a lower (cheaper) dose once they reach their target.

Is the Oral Wegovy Pill Worth the Cost?

The value proposition of oral Wegovy depends on your situation:

For cash-paying patients: At $149/month for the starting dose, oral Wegovy is the most affordable branded semaglutide option by a wide margin. It is comparable in price to compounded semaglutide but with the advantages of FDA approval, proven clinical trial data, and guaranteed quality. For most cash-paying patients, this represents excellent value.

For insured patients: If your insurance covers GLP-1 medications, the choice between oral and injectable Wegovy is more about preference than price. Both will have similar copays. The oral pill may be preferred by patients who dislike needles or want a medication that does not require refrigeration.

Compared to doing nothing: Obesity-related healthcare costs average $1,861 more per year than normal-weight individuals. The cost of GLP-1 treatment, combined with the weight loss and cardiovascular benefits, represents a strong long-term value proposition for eligible patients. See our guide on GLP-1 for weight loss for detailed efficacy data.

Future Pricing Outlook

Several factors may affect oral Wegovy pricing in the coming months and years:

• Generic semaglutide: Novo Nordisk's primary semaglutide patent expires in 2026 in some international markets. US generic availability is further out, but competition will eventually drive prices down.
• Competitor oral GLP-1s: Orforglipron (Eli Lilly's oral GLP-1) is in late-stage clinical trials and could provide price competition when launched.
• Insurance expansion: As more insurers add GLP-1 coverage and Medicare policies evolve, out-of-pocket costs should decrease for the majority of patients.
• Compounding regulations: The evolving legal status of compounded semaglutide affects pricing dynamics. If compounding access further narrows, brand-name options become the primary choice.